Synthesis, spectral characterization, In-vitro antibacterial and antifungal activities of novel (2e)-ethyl-2-(2-(2, 4-dinitrophenyl) hydrazono)-4-(naphthalen-2-yl)-6-arylcyclohex-3-enecarboxylates

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 4, 2011, Pages 711-725

  Kanagarajan, V ^a   Thanusu, J ^a   Gopalakrishnan, M ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

(2E) ethyl 2 (2 (2, 4 dinitrophenyl)2hydrazono) 4 (naphthalen 2 yl) 6 arylcyclohex 3 enecarboxylates; 2,4 Dinitrophenyl hydrazine; Antibacterial activity; Antifungal activity; Ethyl 4 (naphthalen 2 yl) 2 oxo 6 arylcyclohex 3 enecarboxylates

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBOXYLIC ACID DERIVATIVE; CIPROFLOXACIN; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 4 (NAPHTHALEN 2 YL) 6 (4 NITROPHENYL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 4 (NAPHTHALEN 2 YL) 6 P TOLYLCYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 4 (NAPHTHALEN 2 YL) 6 PHENYLCYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 6 (3 CHLOROPHENYL) 4 (NAPHTHALEN 2 YL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 6 (4 BROMOPHENYL) 4 (NAPHTHALEN 2 YL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 6 (4 CHLOROPHENYL) 4 (NAPHTHALEN 2 YL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 6 (4 FLUOROPHENYL) 4 (NAPHTHALEN 2 YL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 2 [2 (2,4 DINITROPHENYLHYDRAZONO)] 6 (4 METHOXYPHENYL) 4 (NAPHTHALEN 2 YL) CYCLOHEX 3 ENECARBOXYLATE; ETHYL 4 (NAPHTHALEN 2 YL) 2 OXO 6 P TOLYLCYCLOHEX 3 ENECARBOXYLATE; ETHYL 4 (NAPHTHALEN 2 YL) 2 OXO 6 PHENYLCYCLOHEX 3 ENECARBOXYLATE; ETHYL 4 (NAPHTHALEN 2 YL) 6 (4 NITROPHENYL) 2 OXO CYCLOHEX 3 ENECARBOXYLATE; ETHYL 6 (3 CHLOROPHENYL) 4 (NAPHTHALEN 2 YL) 2 OXOCYCLOHEX 3 ENECARBOXYLATE; ETHYL 6 (4 BROMOPHENYL) 4 (NAPHTHALEN 2 YL) 2 OXOCYCLOHEX 3 ENECARBOXYLATE; ETHYL 6 (4 CHLOROPHENYL) 4 (NAPHTHALEN 2 YL) 2 OXOCYCLOHEX 3 ENECARBOXYLATE; ETHYL 6 (4 FLUOROPHENYL) 4 (NAPHTHALEN 2 YL) 2 OXOCYCLOHEX 3 ENECARBOXYLATE; ETHYL 6 (4 METHOXYPHENYL) 4 (NAPHTHALEN 2 YL) 2 OXOCYCLOHEX 3 ENECARBOXYLATE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; HETERONUCLEAR SINGLE QUANTUM COHERENCE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MELTING POINT; MICHAEL ADDITION; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; MUCOR; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; RHIZOPUS; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

EID: 84859550522     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sevim Rollas S and Kucukguzel G. Biological activities of hydrazone derivatives. Molecules (2007) 12: 19101939-.
2. Nayyar A and Jain R. Recent advances in new structural classes of anti-tuberculosis agents. Curr. Med. Chem. (2005) 12: 18731886-.
3. Scior T and Garcés-Eisele SJ. Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides and hydrazones: A critical review. Curr. Med. Chem. (2006) 13: 22052219-.
4. Janin Y. Antituberculosis drugs: Ten years of research. Bioorg. Med. Chem. (2007) 15: 24792513-.
5. Abbasi Nazari M, Kobarfard F, Tabarsie P, Azimi M and J Salamzadeh. Effect of antituberculosis regimen containing ethambutol on serum magnesium level in pulmonary tuberculosis patients. Iranian J. Pharm. Res. (2009) 8: 3336-.
6. Dimmock JR, Vashishtha SC and Stables JP. Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds. Eur. J. Med. Chem. (2000) 35: 241248-.
7. Ergenc N and Gunay NS. Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives. Eur. J. Med. Chem. (1998) 33: 143148-.
8. Todeschini AR, Miranda AL, Silva CM, Parrini SC and Barreiro EJ. Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives. Eur. J. Med. Chem. (1998) 33: 189199-.
9. Lima PC, Lima LM, Silva KC, Leda PH, Miranda ALP, Fraga CAM and Barreiro E. Synthesis and analgesic activity of novel N-acylhydrazones and isosters, derived from natural safrole. Eur. J. Med. Chem. (2000) 35: 187203-.
10. Fraga AGM, Rodrigues CR, Miranda ALP, Barreiro EJ and Fraga CAM. Synthesis and pharmacological evaluation of novel heterocyclic acylhydrazone derivatives, designed as PAF antagonists. Eur. J. Pharm. Sci. (2000) 11: 285290-.
11. Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR and Richardson DR. Novel aroyl hydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasites. Int. J. Biochem. Cell Biol. (2004) 36: 401-407.
12. Kucukguzel SG, Rollas S, Erdeniz H and Kiraz M. Synthesis, characterization and antimicrobial evaluation of ethyl 2-arylhydrazono-3-oxobutyrates. Eur. J. Med. Chem. (1999) 34: 153160-.
13. Silva AG, Zapata-Suto G, Kummerle AE, Fraga CAM, Barreiro EJ and Sudo RT. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues. Bioorg. Med. Chem. (2005) 13: 34313437-.
14. Pandey J, Pal R, Dwivedi A and Hajela K. Synthesis of some new diaryl and triaryl hydrazone derivatives as possible estrogen receptor modulators. Arzneimittelforschung (2002) 52: 3944-.
15. Arctander S. Perfume and Flavour Chemicals (Aroma Chemicals). Montclair, NJ (1969).
16. 42- as a reusable heterogeneous catalyst. Lett. Org. Chem. (2006) 6: 484488-.
17. Gopalakrishnan M, Sureshkumar P, Thanusu J and Kanagarajan V. Design, 'one-pot' synthesis, characterization, antibacterial and antifungal activities of novel 6-aryl-1,2,4,5-tetrazinan-3-thiones in dry media. J. Sulfur Chem. (2007) 28: 383392-.
18. Gopalakrishnan M, Thanusu J, Kanagarajan V, Govindaraju R. Design, synthesis and in-vitro microbiological evaluation of 6,6-dimethyl-7,9-diaryl-1,2,4,8-tetrazaospiro[4.5]decan-3-thiones-A new series of 'Tailor-made' compounds. J. Enz. Inhib. Med. Chem. (2009) 24: 406412-.
19. Gopalakrishnan M, Thanusu J and Kanagarajan V. Design, synthesis, spectral analysis and in-vitro microbiological evaluation of biolabile 2-phenyl-3-(4,6-diarylpyrimidin-2-yl)thiazolidin-4-one. J. Enz. Inhib. Med. Chem. (2009) 24: 10881094-.
20. Gopalakrishnan M, Thanusu J and Kanagarajan V. Synthesis and biological evaluation of 5,7-diaryl-4,4-dimethyl-4,5,6,7-tetrahydropyridino[3,4-d]-1,2,3-thiadiazoles. Med. Chem. Res. (2007) 16: 392401-.
21. Guthrie W and Wang XP. The aldol condensation of acetophenone with acetone. Can. J. Chem. (1991) 69: 339.
22. Dhar MH, Dhar, MM, Dhawan BN, Mehrotra BN and Ray C. Screening of Indian plants biological activity. Part I. Indian J. Exp. Biol. (1968) 6: 232247-.
23. Lipinski CA, Lombardo F, Dominy BW and Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliver. Rev. (1997) 23: 325-.
24. Purser S, Moore PR, Swallow S and Gouverneur V. Fluorine in medicinal chemistry. Chem. Soc. Rev. (2008) 37: 320330-.